*KURA ONCOLOGY RECEIVES SECOND $30 MILLION DEVELOPMENT MILESTONE PAYMENT IN AML MENIN INHIBITOR PROGRAM WITH KYOWA KIRIN
*KURA ONCOLOGY INC - EXPECTS UP TO $315 MILLION IN ADDITIONAL MILESTONES
((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 03-NOV-202521:02:00.207 GMT